NRC HEALTH (NRC)
NRC HEALTH (NRC) from its SEC filings: 2025 revenue $137.4 million (-4% vs the year before), net margin 8%, free cash flow $15.7 million. Insider trades, recent filings and a price chart. Free.
| Exchange | Nasdaq |
| Industry | Services-Commercial Physical & Biological Research |
| Revenue (2025) | $137.4 million |
| Revenue growth | -4% |
| Net income | $11.6 million |
| Net margin | 8.4% |
| Free cash flow | $15.7 million |
| Diluted EPS | $50.00 |
| Latest quarter (Q3 2026 (calendar)) revenue vs a year earlier | +11% |
| Cash | $3.6 million |
| Long-term debt | $98.1 million |
| Share count, 1 year | -6% |
| Fundamentals check | Strong fundamentals |
Source: SEC EDGAR company filings (XBRL), updated 2026-11-08. Education only, not financial advice.